Five empty PLGA microparticles were suspended in 50 uL of methyl cellulose (15 mg/ml; Sigma-Aldrich) solution.
Particles were aspirated into an 18-gauge Monoject filter needle (Covidien) and administered subcutaneously into the rear flank of SKH1-Elite mouse.
Mice were euthanized and their skins of the entire rear flank were harvested by scissors after 2, 8, and 30 days. The color of PLGA microparticles will turn from transparent to white over time after administration" to " The color of PLGA microparticles turns from transparent to white over time after administration.
The skin was then cut into ~1 cm×1 cm square containing PLGA microparticles, spread and pinned on a thin piece of wax (~1.5 cm×1.5 cm ×0.5 cm, length × width × thickness) using pushpins, fixed in formalin-free fixative (Sigma-Aldrich) for 24 hours, and transferred to 70% ethanol in a glass jar.
The nearest edge of the skin to PLGA microparticles was marked with tissue marking dye.
Skin samples were then embedded in paraffin. Subsequently, the embedded samples were sectioned using a microtome machine. Cross-sections measuring 5 μm in thickness were then cut from the side marked with tissue dye. The microtome was adjusted to 100 μm between each step. This process was repeated until reaching the depth necessary to visualize and analyze the PLGA microparticles.
The skin sections containing PLGA microparticles were then stained with hematoxylin and eosin stain and imaged using an Aperio AT2 Slide Scanner (Leica Biosystems).
Related files
Biodegradation of PLGA protocol.docx
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Lu, X and Jaklenec, A(2020). Biodegradation of PLGA-MPs. Bio-protocol Preprint. bio-protocol.org/prep471.
Lu, X., Miao, L., Gao, W., Chen, Z., McHugh, K. J., Sun, Y., Tochka, Z., Tomasic, S., Sadtler, K., Hyacinthe, A., Huang, Y., Graf, T., Hu, Q., Sarmadi, M., Langer, R., Anderson, D. G. and Jaklenec, A.(2020). Engineered PLGA microparticles for long-term pulsatile release of STING agonist for cancer immunotherapy . Science Translational Medicine 12(556). DOI: 10.1126/scitranslmed.aaz6606
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.